Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery
2007

Genetic Variants Predict Response to Lung Surgery

Sample size: 203 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hersh Craig P, DeMeo Dawn L, Reilly John J, Silverman Edwin K

Primary Institution: Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA

Hypothesis

Genetic differences may explain variability in response to lung volume reduction surgery (LVRS).

Conclusion

Genetic variants in GSTP1 and EPHX1 were predictive of response to LVRS.

Supporting Evidence

  • A SNP upstream from GSTP1 was associated with change in BODE score.
  • A coding SNP in EPHX1 was associated with change in BODE score.
  • Genetic variants may identify patients most likely to benefit from LVRS.

Takeaway

Some people respond better to lung surgery because of their genes, which can help doctors choose the right treatment.

Methodology

The study analyzed genetic variants in 203 subjects from the NETT Genetics Ancillary Study and their association with four outcome measures of LVRS response.

Potential Biases

Potential spurious associations due to multiple testing and lack of a suitable replication population.

Limitations

The study could not examine survival post-LVRS due to the timing of DNA sample collection and the small sample sizes in some subgroups.

Participant Demographics

Participants were non-Hispanic white patients with severe airflow obstruction and bilateral emphysema.

Statistical Information

P-Value

p = 0.003 for GSTP1 SNP and p = 0.008 for EPHX1 SNP

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1465-9921-8-59

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication